Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Head and Neck Cancer

Free Subscription 18.08.2025 1 BMC Cancer 1 Br J Cancer 2 Br J Oral Maxillofac Surg 1 Clin Cancer Res 3 Dis Esophagus 14 Head Neck 2 Int J Cancer 1 J Clin Endocrinol Metab 2 Laryngoscope 5 Oral Oncol 1 PLoS One 1 Surgery 1 Thyroid

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. LIN X, Liu S, Ding Y, Zhao J, et al
   Contrasting tracheal, bronchus, and lung cancer burdens and care quality: a comparative analysis of China and global trends.
   BMC Cancer. 2025;25:1298.
   PubMed         Abstract available
   
   

   
   Br J Cancer

2. KO JM, Guo C, Leung AK, Chan SC, et al
   Oncogenic NFE2L2 mutations in plasma ctDNA and tumors are predictors and prognosticators of chemoradiation therapy in resectable esophageal squamous cell carcinoma.
   Br J Cancer. 2025 Aug 8. doi: 10.1038/s41416-025-03113.
   PubMed         Abstract available
   
   

   
   Br J Oral Maxillofac Surg

3. ZHANG Y, Guo J, Ren D, Liu T, et al
   Prediction of postoperative complications in patients undergoing head and neck surgery with free-flap reconstruction.
   Br J Oral Maxillofac Surg. 2025;63:486-495.
   PubMed         Abstract available
   
   
4. NAYYAR N, Albakov S, Chegini S, Ahmed A, et al
   Retrospective audit of the recurrence rate amongst pathologically node negative (pN0) staged patients with oral squamous cell carcinoma (OSCC).
   Br J Oral Maxillofac Surg. 2025;63:496-501.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

5. HONORE N, Laliotis G, Aushev VN, Velichko S, et al
   Tumor-informed ctDNA assay to predict outcome in recurrent and/or metastatic squamous cell carcinoma of the head and neck treated with PD-1 inhibitor.
   Clin Cancer Res. 2025 Aug 11. doi: 10.1158/1078-0432.CCR-25-1309.
   PubMed         Abstract available
   
   

   
   Dis Esophagus

6. DEN BOER RB, Sanders ME, Meijer GJ, Haj Mohammad N, et al
   Impact of endoscopic ultrasonography with fine needle aspiration assessing clinical lymph node staging on radiotherapy treatment planning in esophageal cancer patients.
   Dis Esophagus. 2025;38:doaf065.
   PubMed         Abstract available
   
   
7. KO MT, Rizwanullah A, Jafri Z, Fung A, et al
   Chemoprevention of Barrett's Esophagus: a Systematic Review and Comprehensive Assessment of Bias.
   Dis Esophagus. 2025;38:doaf062.
   PubMed         Abstract available
   
   
8. KEMPF ON, Thorsen LBJ, Nerup N, Kjaer DW, et al
   Stage-dependent survival in esophageal cancer: a Danish nationwide cohort study.
   Dis Esophagus. 2025;38:doaf064.
   PubMed         Abstract available
   
   

   
   Head Neck

9. WANG Z, Zhang D, Du Q, Zhang W, et al
   Bilateral Thyroid Ima Arteries Arising From the Brachiocephalic Trunk: A First Case Report.
   Head Neck. 2025;47:E96-E100.
   PubMed         Abstract available
   
   
10. GUNDOG M, Kiraz E
    Ultra-Hypofractionated Radiotherapy for Early-Stage Glottic Cancer: Real-World Data From a Single Center.
    Head Neck. 2025;47:2383-2391.
    PubMed         Abstract available
    
    
11. REN Q, Cui Y, Huang H, Li X, et al
    Magnetic Resonance Imaging and [18F]-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Guided Therapy Improves Survival in Upper Aerodigestive Tract NK/T-Cell Lymphoma, Nasal Type: A Prospective Cohort Study.
    Head Neck. 2025;47:2392-2400.
    PubMed         Abstract available
    
    
12. WIERZBICKA M, Swiatek D, Sikora J, Likus W, et al
    Socioeconomic Disparities in Head Neck Cancer Incidence and Mortality: Regional Wealth-Dependent Analysis in Seniors Cohorts.
    Head Neck. 2025;47:2401-2411.
    PubMed         Abstract available
    
    
13. SJOSTEDT S, Garset-Zamani M, Korsholm K, Agander TK, et al
    HPV-Positive Squamous Cell Carcinoma Metastasis Without Clinical Evidence of Primary: The Posterior Oropharyngeal Wall May Be an Overlooked Location.
    Head Neck. 2025;47:E101-E105.
    PubMed         Abstract available
    
    
14. WONG AW, Hung SY, Wei FC
    Debunking the "Vessel Depleted Neck"-Study of 52 Patients With More Than Three Reconstructions.
    Head Neck. 2025;47:2425-2430.
    PubMed         Abstract available
    
    
15. SCHARNER MK, Owen JM, Nguyen SA, Kejner AE, et al
    Surgical Versus Non-Surgical Treatment of Advanced Oropharyngeal Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis.
    Head Neck. 2025;47:2486-2498.
    PubMed         Abstract available
    
    
16. VAN DE VELDE LJ, Breimer GE, Scheurleer WFJ, de Ridder M, et al
    Sinonasal Intestinal-Type Adenocarcinoma in the Netherlands: A Nationwide Study (2008-2022).
    Head Neck. 2025;47:2531-2540.
    PubMed         Abstract available
    
    
17. KIM J, Wee CW, Lee CG, Keum KC, et al
    Patterns of Initial Lymph Node Involvement and Recurrence in Patients With Maxillary Sinus Squamous Cell Carcinoma.
    Head Neck. 2025;47:2522-2530.
    PubMed         Abstract available
    
    
18. WOOD E, Sherry R, Jones G, Babek JT, et al
    Evaluating Diversity in Thyroid Cancer Clinical Trials: Application of the Clinical Diversity Rating Framework.
    Head Neck. 2025;47:2507-2521.
    PubMed         Abstract available
    
    
19. RODRIGUEZ CP, Wu QV, Ng K, Voutsinas J, et al
    Dual PD-1 and CTLA4 Immune Checkpoint Blockade and Hypofractionated Radiation in Patients With Advanced Salivary Gland Cancers.
    Head Neck. 2025;47:2552-2557.
    PubMed         Abstract available
    
    
20. ZHANG D, Li L
    Prognostic Models for Overall and Disease-Specific Survival in Palate Squamous Cell Carcinoma: Implications for Postoperative Radiotherapy.
    Head Neck. 2025;47:2558-2569.
    PubMed         Abstract available
    
    
21. YOU Z, Han B, Shi Z, Du S, et al
    Single-View Contrastive Learning for Laryngeal Leukoplakia Classification With NBI Laryngoscopy Images.
    Head Neck. 2025;47:2584-2593.
    PubMed         Abstract available
    
    
22. KITCHIN S, Whiteside J, Mahanpour S, Robbins J, et al
    Autologous Arteriovenous Loop Graft Creation for Head and Neck Microsurgical Reconstruction: A Pictorial Essay.
    Head Neck. 2025;47:2627-2633.
    PubMed         Abstract available
    
    

    
    Int J Cancer

23. GEERTS JFM, Vissers PAJ, Mostert B, Wijnhoven BPL, et al
    Hospital variation in treatment for synchronous metastatic esophageal and gastric cancer: A nationwide population-based study in the Netherlands.
    Int J Cancer. 2025 Jun 5. doi: 10.1002/ijc.35491.
    PubMed         Abstract available
    
    
24. ZHANG LT, Wu XY, Zhang HY, Li EM, et al
    Exploring solute carriers as biomarkers and therapeutic targets in esophageal squamous cell carcinoma.
    Int J Cancer. 2025 Aug 11. doi: 10.1002/ijc.70080.
    PubMed         Abstract available
    
    

    
    J Clin Endocrinol Metab

25. CHO YY, Ahn SH, Kim M, Lee EK, et al
    TSH Cut-Offs and Recurrence Risk in Differentiated Thyroid Carcinomas: A Systematic Review and Meta-Analysis.
    J Clin Endocrinol Metab. 2025 Aug 14:dgaf463. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    Laryngoscope

26. MECI A, Goyal N, Goldenberg D
    The Malignant Transformation Rate of Oral Carcinoma In Situ.
    Laryngoscope. 2025 Aug 9. doi: 10.1002/lary.70025.
    PubMed         Abstract available
    
    
27. ASARKAR AA, Gillespie MB, Nathan CO
    Historical Perspective of Landmark Trials in Head and Neck Cancers.
    Laryngoscope. 2025 Aug 13. doi: 10.1002/lary.70038.
    PubMed         Abstract available
    
    

    
    Oral Oncol

28. COLAK G, Demir B
    Letter to the Editor: "Effects of diagnostic delays in head and neck cancer patients presenting to the emergency department".
    Oral Oncol. 2025;168:107579.
    PubMed        
    
    
29. TOSONI A, Di Nunno V, Carlini A, Gatto L, et al
    The role of systemic therapy in patients with recurrent or metastatic head and neck squamous cell carcinoma progressed to immunotherapy: A systematic review and meta analysis.
    Oral Oncol. 2025;168:107582.
    PubMed         Abstract available
    
    
30. ASHOK A, Dimitri S, Plonowska-Hirschfeld K, Wu MP, et al
    Establishing an integrated approach to head and neck cancer treatment and prevention: The Robert Ebert and Greg Stubblefield Head and Neck Tumor Center Model.
    Oral Oncol. 2025;168:107591.
    PubMed         Abstract available
    
    
31. LAVANYA K, Sathishkumar K, Nallusamy D
    Letter to the editor: A preliminary exploration of surgical strategies for solitary papillary thyroid carcinoma on the isthmus.
    Oral Oncol. 2025;168:107590.
    PubMed        
    
    
32. HONGO T, Hirano Y, Tarutani Y, Omori H, et al
    Prospective study of algorithm-based chemoradioselection to optimize treatment intensity for advanced head and neck cancer.
    Oral Oncol. 2025;168:107585.
    PubMed         Abstract available
    
    

    
    PLoS One

33. BRUCKNER J, Rohrer Bley C, Rampazzo A, Unterkirhers S, et al
    Evaluation of acute ocular toxicity after definitive-intent radiation therapy in canine sinonasal tumors.
    PLoS One. 2025;20:e0329073.
    PubMed         Abstract available
    
    

    
    Surgery

34. POLLMANN L, Weberskirch S, Petry M, Kubasch S, et al
    Indocyanine green quantification in full robotic esophagectomy using an unsupervised learning approach.
    Surgery. 2025;184:109405.
    PubMed         Abstract available
    
    

    
    Thyroid

35. ITO Y, Miyauchi A, Yamamoto M, Kihara M, et al
    Dynamic Risk Assessment Using Unstimulated Serum Thyroglobulin Level and Thyroglobulin Doubling Rate after Total Thyroidectomy for Papillary Thyroid Carcinoma.
    Thyroid. 2025 Aug 11. doi: 10.1177/10507256251367242.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.